维普中文期刊产品整合服务
115篇 您的检索式:作者名="Drozdz"
    题名 作者 年代 出处 被引量
1Blood Serum Levels of IL-2, IL-6, IL-8, TNF-α and IL-1β in Patients on Maintenance Hemodialysis显示文摘Cytokines 是有免疫力的反应和煽动性的反应的必要调停人。有长期的肾的失败(CRF ) 的病人通常与除了 dialyzer 膜的 bioincompatibility 与损害的肾功能和尿毒症的毒素的累积联系的有免疫力的功能的畸形介绍。在 hemodialysis (HD ) 期间会议, cytokines 主要被内毒素类型混合物在有 dialyzer 的 dialyzer 液体,补充因素和直接接触激活的单核白血球释放膜。学习包括了 15 个 CRF 病人, 36.4 吗??Jacek Rysz Maciej Banach Aleksandra Cialkowska-Rysz Robert Stolarek Marcin Barylski Jaroslaw Drozdz Piotr Okonski 2006Cellular & Molecular Immunology2006,3,2:14
2The circulating non-coding RNA landscape for biomarker research: lessons and prospectsfrom cardiovascular diseases显示文摘人的染色体的弥漫的抄写为无数非编码的 RNA 分子(ncRNAs ) 的生产负责有规章的功能的他们的一些。在心血管的生物学的 ncRNAs 的枢轴的角色在最后十年被揭开了,从在心血管的开发和功能的 micro-RNAs 的参与的描述开始,并且作为心血管的疾病的 biomarkers 由传播 ncRNAs 的使用列在后面。人的非编码的 secretome 被几 RNA 种填写在身体液体传播并且能为诊断和结果预言被用作 biomarkers。在心血管的疾病,分泌了 ncRNAs 包括心肌的梗塞,心脏的失败,和 atrial 纤维性颤动被描述了为几个条件的 biomarkers。在传播之中, ncRNAs, micro-RNAs (miRNAs ) ,长 noncoding RNA (lncRNAs ) 和圆形的 RNA (circRNAs ) 在不同心血管的疾病作为 biomarkers 被建议了。与标准 biomarkers 比较, ncRNAs 的生物化学的性质为更好的稳定性和灵活存储提供样品,和增加的敏感和特性的条件。在这评论,我们把当前的趋势和 ncRNA secretome 部件的使用的未来前景描述为心血管的疾病的 biomarkers,包括与他们的分泌物机制和规章的行动联系的开的问题。Ewa STFPIEN Marina C COSTA Szczepan KURC Anna DROZDZ Nuno CORTEZ-DIAS Francisco J ENGUITA 2018Acta Pharmacologica Sinica2018,39,7:14
3Immunological Aspects of the Statins' Function in Patients with Heart Failure:A Report from the Annual Conference of ESC-Heart Failure 2005显示文摘The annual meeting of the Heart Failure Association of ESC in Lisbon, in June 2005, was exceptionally successful.There were many very interesting presentations and workshops with the unique title: Statins in heart failureCholesterol-lowering is not the only goal Heart failure (HF) is a progressive disease with coronary artery disease (CAD) as the most often underlying etiology. Treatment to prevent progression of heart failure has been targeted to reverse the consequences of HF and to a less extent the cause - the atherosclerotic plaque itself. On the average 50% of patients with heart failure are treated with lipid intervention. Lipid-lowering treatment with statins clearly reduces morbidity and mortality of patients with documented CAD. Since the prevalent etiology of heart failure is CAD, its prevention may reduce heart failure progression. However, recent studies suggest that pleiotropic effects of statins are more important than the influence related to their cholesterol lowering mechanism. Furthermore it is suggested that low levels of circulating lipoproteins and cholesterol may be independent predictors of impaired outcome in patients with heart failure. There are some possible explanations for this finding. High levels of cholesterol can be beneficial to heart failure patients; cholesterol-rich serum lipoproteins are able to modulate inflammatory immune function because they bind and detoxify bacterial lipopolysaccharide, a very strong stimulator of the release of proinflammatory cytokines that promote heart failure progression and death. So current recommendations strongly emphasize that the aim of treatment of HF is not to lower cholesterol.Maciej Banach Jarostaw Drozdz Piotr Okonski Jacek Rysz 2005Cellular & Molecular Immunology2005,2,6:7
4Multifractality in the Stock Market:Price Increments Versus Waiting Times显示文摘OSWIECIMKA P KWAPIE N′ J DROZDZ S 2005Physica A2005,347,:1
5Myeloperoxidase-mediated protein oxidation:its possible biological functions显示文摘Naskalski JW Marcinkiewicz J Drozdz R 2002Clin Chem Lab Med2002,40,5:1
6Stock Market Return Disreibutions: From Past to Present显示文摘DROZDZ S FORCZEK M KWAPIEN J 2007Phys A2007,383,:1
7Reverse cholesterol transport processes and their role in artherosclerosis regression 显示文摘CHACHAJ A DROZDZ K SZUBA A 2008Postcpy Biochem2008,54,3:1
8Gamma- glutamyl transferase dependent generation of reactive oxygen species from a glutathione/transferrin system 显示文摘Drozdz R Parmentier C Haehad H 1998Free Radie BiolMed1998,25,:1
9Myeloperoxidase mediated protein oxidation: its biological functions 显示文摘Naskalski JW Marcinkiewicz J Drozdz R 2002Clin Chen Lab Med2002,40,5:1
10The assessment of heart function in children with chronic kidney disease (CKD)显示文摘Drozdz D Kordon Z Pietrzyk JA 2008Pol Merkur Lekarski2008,244,:1
11Myeloperoxidase - mediated protein oxidation: its possible biological functions 显示文摘Naskalski JW Marcinkiewicz J Drozdz R 2002Clin Chem Lab Med2002,40,1:1
12Zine vitamins A and B retinol-binding protein in sera of patients ancer of the larynx显示文摘Drozdz M 1989Neplasma1989,36,:1
13The assessment of heart function in chlildren with chronic kidney disease(CKD)显示文摘Drozdz D Kordon Z Pietrzyk JA 2008Pol Merkur Lekarski2008,24,4:1
14Concentration of selenium and vitamin E in the serum of women with malignant genital neoplasms and their family members显示文摘DROZDZ M TTOMATA J JENDRYCZKO A 1989Ginekol Pol1989,60,6:1
15Assessment and prevalence of depression in women 45-55 years of age visiting gynecological clinics in Poland:screening for depression among midlife gynecologic patients 显示文摘Wojnar M Drozdz W Araszkiewicz A 2003Arch Women Ment Health2003,6,3:1
16Monitoring the setting and early hardening of concrete using an ultrasonic waveguide显示文摘Pu S H Cegla F Drozdz M 2004Insight2004,46,6:1
17Enlarged left atrium is a simple and strongpredictor of poor prognosis in patients after myocardialinfarction显示文摘WIERZBOWSKA-KRABIK K KRZEMINSKA-PAKULA M DROZDZ J 2008Echocardiography2008,25,1:1
18Depres- sive symptoms and cognitive dysfunction in patients with hepatitis C treated with interferon -e and ribavirine显示文摘DROZDZ W BORKOWSKA A HALOTA W 2008Arch Psychiat Psychother2008,1,:1
19Clinical aspects of assessment of endothelial function 显示文摘Kaspizad JD Klosinska M Drozdz J 2006Pharmacol Rep2006,,:1
20Comparison of the Antioxidant Properties of Commonly Consumed Commercial Teas显示文摘Anna Pekal Paulina Drozdz Krystyna Pyrzynska 2012International Journal of Food Properties2012,,5:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费